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Antimicrobial resistance rates for shigella, campylobacter, nontyphoidal salmonella, and enterotoxigenic
Escherichia coli were compared for Vietnam and Thailand from 1996 to 1999. Resistance to trimethoprim-
sulfamethoxazole, ampicillin, chloramphenicol, and tetracycline was common. Quinolone resistance
remains low in both countries, except among campylobacter and salmonella organisms in Thailand. Nalid-
ixic acid resistance among salmonellae has more than doubled since 1995 (to 21%) in Thailand but is not
yet documented in Vietnam. Resistance to quinolones correlated with resistance to azithromycin in both
campylobacter and salmonella in Thailand. This report describes the first identification of this correlation
and its epidemiologic importance among clinical isolates. These data illustrate the growing magnitude of
antibiotic resistance and important differences between countries in Southeast Asia.
ntimicrobial resistance among enteric pathogens in devel-
oping countries is a critical area of public health concern.
The usual causative agents of dysentery—shigella, campylo-
bacter, and nontyphoidal salmonella—are becoming increas-
ingly resistant to most agents commonly in use (1-3). The
current recommendation for management of travelers’ diar-
rhea is self-therapy with antibiotics if illness develops (4,5);
fluoroquinolones are standard treatment in much of the world.
Although travelers’ diarrhea has traditionally been associated
with enterotoxigenic Escherichia coli (ETEC), some studies
from Asia have shown that campylobacter is of equal or
greater importance (6-8). In the early 1990s, fluoroquinolone-
resistant strains of campylobacter rapidly became prevalent in
Thailand, increasing from 0% to 84% of isolates from 1990 to
1995 (1). 
Azithromycin has been suggested as a replacement for qui-
nolones for empiric treatment of travelers’ diarrhea in Thai-
land (9). Although this drug may be a reasonable choice for
travelers, its high cost precludes its use as routine treatment for
dysentery in disease-endemic areas. Furthermore, the emer-
gence in Thailand of campylobacter resistant to both quinolo-
nes and azithromycin (1) threatens the continued usefulness of
both. 
The seriousness of the problem has prompted calls for
improved surveillance for antimicrobial resistance in develop-
ing countries, which could provide early warnings of the emer-
gence of resistant bacterial strains (10). The prevalence of
quinolone- and macrolide-resistant campylobacter in areas of
Southeast Asia other than Thailand is unknown, and resistance
patterns in Thailand may not apply to other countries in the
region. Poorer countries such as Vietnam could benefit by
avoiding a rush to newer, more expensive agents if sensitivity
to older drugs could be demonstrated. Data from Vietnam rela-
tive to this issue are scarce or outdated. Surveillance data from
the World Health Organization’s Western Pacific Region col-
laboration for 1992-93 reported 0% and 2% prevalence of
fluoroquinolone resistance among nontyphoidal salmonella
and shigella, respectively, in Vietnam, although the numbers of
isolates and shigella groups were not specified (11). Sullivan
et al. (12) reported resistance rates in >3,000 isolates of shi-
gella, salmonella, and Escherichia coli collected before 1971
from U.S. soldiers and Vietnamese residents with diarrhea;
levels of resistance to tetracycline, chloramphenicol, strepto-
mycin, and novobiocem were high, particularly among shigel-
lae. Other than these two studies, no data have been published
in English on resistance patterns in enteric diarrheal pathogens
in Vietnam, and no campylobacter resistance data from this
country have ever been published.
The Armed Forces Research Institute of Medical Sciences
in Bangkok has been coordinating studies of the causes, epide-
miology, and treatment of diarrheal diseases in Thailand and
Vietnam. Antibiotic susceptibility of bacterial isolates, includ-
ing shigella, ETEC, and nontyphoidal salmonella from
patients with diarrhea, have been tested against the most com-
mon antibiotics, including ampicillin, tetracycline, chloram-
phenicol, trimethoprim-sulfamethoxazole (SXT), nalidixic
acid, and fluoroquinolones. In recent years, azithromycin
resistance among these pathogens, as well as the emergence of
fluoroquinolone and azithromycin resistance in campylobacter
species, has been monitored. A review of 15 years of data from
1981 to 1995 has been published (1). Our study further docu-
ments increasing antibiotic resistance in Thailand from 1996
to 1999 and presents resistance data from Vietnam, offering
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insight into regional differences between two countries that are
proximal geographically, but politically and economically distant.
Methods
Source of Isolates
Bacterial isolates from studies of community-acquired
diarrhea conducted in Thailand and Vietnam from 1996 to
1999 were routinely assayed for sensitivity to various antimi-
crobial agents. Populations under study were predominantly
children <5 years of age from both urban and rural environ-
ments but also included small numbers of adult U.S. soldiers
on military maneuvers in Thailand. Some isolates were
obtained from asymptomatic persons. These data archives
were searched initially for all isolates of shigella (other than
Shigella dysenteriae 1), nontyphoidal salmonella, campylo-
bacter, and ETEC. The lists were reviewed for the presence of
duplicate isolates from the same person, and duplicates were
excluded.
Microbiology
Enteric pathogens were cultured and identified by standard
methods (13-15). ETEC isolates were identified with DNA
probes. Antibiotic susceptibilities of shigella, salmonella, and
ETEC were determined by the disk-diffusion method of Bauer
and co-workers (16), with commercially prepared antibiotic
disks containing ampicillin, tetracycline, chloramphenicol,
sulfisoxazole, SXT, streptomycin, azithromycin, nalidixic
acid, and ciprofloxacin. MIC agar-plate dilution methods
(17,18) were used to test for nalidixic acid, ciprofloxacin, and
azithromycin resistance among campylobacter species.
Because of periodic shortages of reagents, not all isolates were
tested to all antimicrobial agents.
Results
Overall, 2,218 isolates were studied, 76% from Thailand
and 24% from Vietnam. Pathogenic bacteria were obtained
from subjects without gastrointestinal symptoms in 4.2%.
Adult travelers (U.S. soldiers on maneuvers) accounted for
6.4% of Thai isolates, but none of the Vietnamese isolates. All
other isolates were obtained from children <5 years of age.
Sixty-one percent of Thai isolates were from an urban setting
(Bangkok). All Vietnamese isolates were rural. All isolates
were obtained either from cohorts enrolled in epidemiologic
studies evaluating the prevalence of bacterial diarrhea patho-
gens or the incidence of diarrhea or from case-control studies
evaluating diagnostic techniques.
Routine Susceptibility Testing for Shigella Species 
Other than S. dysenteriae 1, ETEC, and Salmonella
From Thailand, 175 shigella (65% S. sonnei, 32% S. flex-
neri), 696 nontyphoidal salmonella, and 203 ETEC isolates
were studied during the 3-year period. From Vietnam, 305 shi-
gella (18% S. sonnei, 71% S. flexneri), 30 salmonella, and 113
ETEC isolates were studied (Table 1).
Among shigella, high levels of resistance to tetracycline
and SXT were noted in both Thailand and Vietnam. Signifi-
cantly less resistance was noted among Thai isolates to ampi-
cillin (29% vs. 77%, p<0.05) and chloramphenicol (21% vs.
64%, p<0.05). Sorting by shigella group showed that nearly all
the difference between Thai and Vietnamese isolates was
accounted for by differences in the prevalence and susceptibil-
ity of S. sonnei compared with the more resistant S. flexneri
strains. In Thailand, S. sonnei was almost all susceptible to
ampicillin and chloramphenicol; in Vietnam, S. sonnei was
more commonly resistant to these agents.
ETEC isolates demonstrated high-level resistance in both
countries to ampicillin, SXT, tetracycline, and sulfisoxazole,
but chloramphenicol resistance was relatively low in both
countries. In contrast, nontyphoidal salmonella from Thailand
had consistently and substantially higher levels of resistance to
all agents, compared with those from Vietnam. Serogroup B
salmonellae in Thailand were generally more resistant than
other serogroups, except for serogroup C isolates, which were
relatively more resistant to nalidixic acid and azithromycin.
Quinolone and Macrolide Resistance among Shigella, 
Salmonella, and ETEC
Resistance to nalidixic acid was rare among shigella (<1%)
and ETEC (3%) in both Thailand and Vietnam but was more
common among Thai salmonella (21%). Resistance to cipro-
floxacin was documented in <1% of isolates, including two
salmonellae (from Thailand) and four ETEC (three from Thai-
land, one from Vietnam). No shigellae were resistant to ciprof-
loxacin in either country (Table 1).
With the exception of S. sonnei, azithromycin resistance
was found in ≤ 8% of shigella, salmonella, and ETEC, with no
significant difference between Vietnam and Thailand. Azithro-
mycin resistance was present in 28% of S. sonnei isolates from
Vietnam but only 2% of Thai isolates (p<0.05).
Resistance of Campylobacter to Quinolones and 
Macrolides
We studied 608 campylobacter isolates from Thailand and
88 from Vietnam. Resistance to nalidixic acid (73% vs. 7%
respectively, p<0.05) and ciprofloxacin (77% vs. 7% respec-
tively, p<0.05) differed markedly between Thai and Vietnam-
ese isolates. Among Vietnamese isolates, quinolone resistance
was predominantly among Campylobacter coli rather than C.
jejuni, but rates among Thai isolates were similar between spe-
cies. Resistance to azithromycin was low in Thailand (6%),
where it predominated among C. coli. No azithromycin resis-
tance was present in Vietnamese isolates (Table 1).
Co-Resistance to Quinolones and Macrolides 
among Campylobacters and Salmonellae
Vietnamese isolates of campylobacter were uniformly sen-
sitive to azithromycin, so we were unable to examine correla-
tions with quinolone resistance. Among Thai isolates,
however, azithromycin resistance correlated with resistance toEmerging Infectious Diseases  •  Vol. 8, No. 2, February 2002 177
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ciprofloxacin (p=0.007) (Table 2). Among  campylobacter
tested to both these agents, all isolates (n=29) that were resis-
tant to azithromycin were also resistant to ciprofloxacin.
Based on the 23% prevalence of ciprofloxacin sensitivity
among azithromycin -susceptible strains, a similar rate of dis-
cordance among azithromycin-resistant strains would be
expected if these resistance patterns were independent. Co-
resistant isolates included both C. coli (n=22) and C. jejuni
(n=7), were composed of multiple serogroups and resistance
profiles, were present in both travelers and indigenous Thais,
and were dispersed geographically around Thailand and tem-
porally over the 4 years of data; therefore, they are not likely
to be clonally related. These isolates were significantly more
likely to be C. coli (76%) than were azithromycin sensitive
isolates (C. coli 15%; p<0.001).
Too few salmonellae were resistant to ciprofloxacin for
analysis of cross-resistance; however, among isolates tested
for resistance to both the first-generation quinolone nalidixic
acid and azithromycin (Table 3), a highly significant correla-
tion was found (p<0.001). Based on the 31% prevalence of
nalidixic acid resistance among azithromycin sensitive strains,
a similar proportion would be expected among azithromycin-
Table 1. Antibiotic resistance patterns among selected enteric pathogens in Thailand and Vietnam, 1996–999a
Pathogen Site
AM CM SXT NA CIP TE AZM
N% R N% RN% RN% RN% RN % R N % R
ETEC Thailand 203 54 203 13 203 51 203 3 203 2 203 43 68 4
Vietnam 113 67 113 17 113 63 112 <1 113 <1 113 65 37 3
Salmonella (all) Thailand 696 28 696 26 696 37 696 21 696 <1 695 59 284 5
Vietnam 30 3 30 7 30 10 30 0 30 0 30 13 19 0
  Group B Thailand 258 49 258 45 258 67 258 23 258 <1 258 77 82 1
V i e t n a m60 606060606 0 3 0
  Group C Thailand 192 5 192 13 192 12 192 33 192 0 191 62 101 12
V i e t n a m10 101010101 0 1 0
  Group D Thailand 68 31 68 31 68 38 68 18 68 0 68 46 28 4
V i e t n a m70 7 1 4 7 1 4 70707 1 4 0
  Group E Thailand 133 24 133 11 133 16 133 4 133 0 133 18 52 5
V i e t n a m1 40 1 401 471 401 401 4 7 1 0 0
  Other Thailand 45 9 45 11 45 16 45 4 45 0 45 18 21 5
V i e t n a m2 5 02 5 0 2 5 0 202021 0 0 1 0
Shigella (all) Thailand 175 29 175 21 175 90 175 <1 175 0 175 91 68 2
Vietnam 305 77 305 64 305 78 305 <1 305 0 305 80 233 8
  G r o u p  A T h a i l a n d 30 3030303033 3 0 N A
V i e t n a m6 5 06 1 7 6 5 0 606065 0 6 0
  Group B Thailand 56 82 56 61 56 86 56 0 56 0 56 96 18 0
Vietnam 216 84 216 74 216 83 216 <1 216 0 216 87 165 5
  G r o u p  C T h a i l a n d 20 202020202 0 0 N A
V i e t n a m2 85 4 2 84 62 86 82 8 0 2 8 0 2 8 7 5 2 2 0
  Group D Thailand 114 4 114 3 114 97 114 <1 114 0 114 92 50 2
Vietnam 55 62 55 36 55 67 55 0 55 0 55 60 40 28
Campylobacter Thailand ND ND ND 608 73 531 77 ND 520 6
Vietnam ND ND ND 88 7 85 7 ND 62 0
  C. jejuni Thailand ND ND ND 489 72 426 75 ND 415 2
Vietnam ND ND ND 71 1 69 1 ND 48 0
  C. coli Thailand ND ND ND 108 75 94 80 ND 94 26
V i e t n a mN D N D N D 1 72 91 63 1N D 1 4 0
aAM=ampicillin; CM=chloramphenicol; SXT=trimethoprim-sulfamethoxazole; NA=nalidixic acid; CIP=ciprofloxacin; TE=tetracycline; AZM=azithromycin; ND=not done; 
%R=percent resistant; NA=not applicable.RESEARCH
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resistant strains if the two were independent, rather than the
80% documented.
Multiple-Antibiotic Resistance among Shigellae, 
Salmonellae, and ETEC
Multiple resistance to ampicillin, chloramphenicol, tetra-
cycline, SXT, and streptomycin was quite common among shi-
gella isolates in both Thailand and Vietnam, but was
significantly more so in Vietnam (46% vs. 21%, p<0.001).
Lower levels of multiple resistance to these drugs were noted
among salmonella and ETEC isolates from both countries (3%
to 7%).
Association between Symptoms and Prevalence 
of Antimicrobial Resistance 
No association was found with presence or absence of gas-
trointestinal symptoms among isolates from Vietnam or
among campylobacter or shigella isolates from Thailand. Thai
ETEC and salmonellae that were isolated from participants
with symptoms were significantly more likely to be resistant
across the spectrum of antimicrobial agents studied (Mantel-
Haensel summary chi square p=0.01 and p<0.01, respec-
tively).
Discussion
This study points out several new findings relative to anti-
microbial resistance among enteric pathogens in Southeast
Asia. We have documented the existence of quinolone resis-
tance among campylobacter, shigella, and ETEC in Vietnam.
If the pattern of campylobacter in Thailand holds true in Viet-
nam, one can expect rapidly increasing resistance rates to qui-
nolones over the next few years in this genus. The reasons for
the marked difference in resistance rates to this class of drugs
between the two countries are unknown but likely reflect dif-
ferences in human and veterinary use of fluoroquinolones.
Quinolone resistance among nontyphoidal salmonella was
not seen in isolates from Vietnam, and ciprofloxacin resistance
remains rare among this species in Thailand; however, pro-
gressive resistance to nalidixic acid among Thai isolates is
cause for concern. Hoge (1) documented steadily increasing
nalidixic acid resistance among nontyphoidal salmonellae in
Thailand, from <1% in 1991-92 to 4% in 1993-94 and 9% in
1995. We documented 21% resistance in this genus during
1996 to 1999, more than double 1995 rates (chi square for
trend, p<0.001). As resistance to nalidixic acid due to first-step
resistance mutations is generally thought to precede resistance
to fluoroquinolones (19), close continued monitoring of resis-
tance rates to both these drugs among nontyphoidal salmonel-
lae is warranted.
Although cases of infections due to macrolide- and fluoro-
quinolone-resistant campylobacter have been reported, these
have usually been among immunocompromised persons who
have received multiple antibiotics (20-22). Our study is the
first to document a statistical correlation between these two
resistance patterns among a large number of community-
acquired enteric isolates. Although the prevalence of azithro-
mycin resistance remains relatively low in Thailand (6%)
while ciprofloxacin resistance is high (77%), our study had
sufficient power to confirm that the 100% correlation between
resistance to these two agents was not likely due to chance.
Previous studies of smaller numbers of azithromycin-resistant
isolates from Thailand also support this 100% correlation
(1,7,9). Resistance to quinolones is generally mediated by
mutations in the chromosomal genes for DNA gyrase or
topoisomerase IV, which are targets of action by the quinolone
class, or less commonly in genes responsible for membrane
flux of the drug (19), including plasmid-mediated enhanced
efflux mechanisms. Resistance to macrolides most commonly
results from mutations in the genes encoding ribosomal pro-
teins but has also been associated with decreased permeability
of the cell envelope in enterobacteriaceae, including plasmid-
mediated mechanisms (21,23). Cross-resistance due to
decreased membrane permeability has been documented
between quinolones and chloramphenicol, trimethoprim, tetra-
cycline, and cefoxitin, but not macrolides (19). Possible novel
cross-resistance mechanisms in these isolates deserve to be
more closely evaluated, as a common plasmid-mediated mech-
anism would increase the likelihood of horizontal spread.
Although resistance to quinolones among campylobacters
from Vietnam was markedly lower than that from Thailand,
multidrug resistance to other agents among Vietnamese shi-
gella isolates was significantly higher than among Thai iso-
lates, perhaps reflecting differences in human use patterns. In
Vietnam in 1997, ampicillin, SXT, tetracycline, and chloram-
phenicol were the antimicrobial agents most commonly dis-
pensed over the counter (24). Thai data from 10 years earlier
(1987) document common dispensing of the same four drugs
by Bangkok pharmacists (25), although fluoroquinolones were
more frequently used for children with diarrhea admitted to
Thai hospitals during 1990-1992 (26), and quinolones have
Table 2. Co-resistancea to azithromycin (AZM) and ciprofloxacin 
(CIP) among campylobacter isolates in Thailand, 1996–1999
AZM
Ra S
CIP R 29b 358
S0 1 0 9
aR = resistant; S = sensitive.
bChi square = 7.4, p=0.007.
Table 3. Co-resistancea to azithromycin (AZM) and nalidixic acid 
(NA) among salmonella isolates in Thailand
AZM
Ra S
NA R 12b 55
S3 1 2 2
aR = resistant; S = sensitive. 
bChi square = 12.5, p<.001.Emerging Infectious Diseases  •  Vol. 8, No. 2, February 2002 179
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likely become increasingly used in the decade since. Our data
suggest that ampicillin, SXT, tetracycline, and chlorampheni-
col have no reasonable role in the empiric treatment of dysen-
tery in Vietnam and should be replaced with quinolones or
macrolides for this indication. Shigellae in Thailand are uni-
formly sensitive to quinolones, but dysentery and travelers’
diarrhea in Thailand are predominantly caused by quinolone-
resistant campylobacter rather than shigella and are thus better
treated empirically with macrolides. Although ampicillin resis-
tance among Thai shigellae was stable during the 4 years of
this study, data from the preceding 15 years (1) demonstrate
that resistance has decreased linearly (chi square for trend,
p<0.001), perhaps reflecting overall reduced human use of this
drug in Thailand as other agents have become more popular.
Concern in Thailand over the possibility of increasing rates
of resistance to azithromycin developing in campylobacter
species is not yet borne out by our study. Hoge (1) demon-
strated azithromycin resistance rates of 15% in 1994 and 7% in
1995 among campylobacters. Our data show 7% resistance
among isolates from 1996 to 1999, failing to confirm an
upward trend.
Limitations of our study include the fact that isolates were
obtained from multiple populations, both indigenous and U.S.
military, in Thailand. However, the rates documented likely
reflect overall resistance among human isolates. Additionally,
the populations under study in Vietnam were all from areas
around Hanoi and therefore do not necessarily reflect resis-
tance rates seen in other parts of Vietnam.
This study highlights the need to be aware of regionally
specific resistance rates to avoid inappropriate antibiotic use.
Additionally, given the evidence for progressive resistance to
the quinolone class and co-resistance between quinolones and
azithromycin among salmonellae and campylobacters, the
need to develop newer classes of antibiotics to treat dysentery
and travelers’ diarrhea is apparent. More efficient use of anti-
microbial agents, for example, avoidance of antimicrobial
therapy for acute noncholera watery diarrhea and use of effec-
tive data-based antimicrobial choices for dysentery, would
likely help limit the development of resistance, although the
impact of these measures would be offset by the widespread
availability of antimicrobial agents over the counter in both
these countries. Effective vaccines against the major causes of
bacterial diarrhea are being developed but are still years away
from commercial production. Parallel drug development
efforts are required.
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Erratum Vol. 8, No. 1
In the article, “A Large Outbreak of Legionnaires’ Disease at a Flower Show, the Netherlands,” by Jeroen W. Den Boer et al., errors appear in two fig-
ures and their legends. 
In Figure 3, part 3a should be identified as IgM and part 3b as IgG. The correct legends are as follows:
Figure 3a. Smoothed mean geometric immunoglobulin (Ig) M antibody titers to Legionella pneumophila of nearest 35 exhibitors in Halls 3 and 4 per
63 cm2 of exhibition area; confirmed and probable cases among exhibitors in halls 3 and 4.
●  = confirmed case in exhibitor;  ❍ = probable case in exhibitor; 
Bu = bubblemat; W = whirlpool spa. 
Figure 3b. Smoothed mean geometric IgG antibody titers to L. pneumophila of 35 exhibitors nearest to whirlpool in halls 3 and 4 per 63 cm2 of exhi-
bition area; exhibitors ill with confirmed and probable cases in halls 3 and 4.
●  = confirmed case in exhibitor; ❍ = probable case in exhibitor; 
Bu = bubblemat; W = whirlpool spa. 
In Figure 4, parts b and c were inadvertently omitted. The complete figure appears below. The correct legends are as follows:
Figure 4. Exhibition hall, West Frisian Flower Show, Bovenkarspel, the Netherlands, 1999. 
4a. Circles indicate locations in water-supply system where water samples were taken. PE = polyethylene.
4b. Assessment of risk for Legionella pneumophila infection, by distance from water-using devices.
4c. Water samples taken and culture status, by distance from water-using devices.
We regret any confusion these errors may have caused. The article is corrected online, available at http://www.cdc.gov/ncidod/eid/vol8no1/01-0176.htm